Dr. Boulton has enjoyed a long-standing, highly prolific research career and is widely regarded as one of the world's experts in macular degeneration, neovascularization of the retina, and corneal wound healing. His lab has been extremely well-funded throughout his career, and he has a long track record of significant publications in high-impact journals, as outlined in his curriculum vitae. As evidence of his respect within the field, he recently finished a term as chair of the Biology of the Visual System (BVS) Study Section for the National Eye Institute (NEI). He also serves on the scientific review panel for the Foundation Fighting Blindness, another large nonprofit focused on blinding retinal disease. He has been invited to speak at many national and international meetings and is a preeminent participant in multiple high-profile meetings within his field.
Maria Grant, MD, professor
Dr. Grant is a highly accomplished researcher in diabetes and retinal disease. She is an incredibly dynamic scientist who has developed broad research programs focusing on stem cell biology and the microvascular complications of diabetic retinopathy. In pursuing these efforts she’s become a leader in these fields, publishing in respected journals and securing significant extramural funding to support her research activities. She currently is funded by the NEI and has a highly fundable score on a second R01 with the NEI. Dr. Grant has authored 195 manuscripts in high-impact, peer-reviewed journals and serves as an editorial reviewer in multiple journals. Her research spans multiple disease areas including diabetic retinopathy, corneal and retinal neovascularization, and retinopathy of prematurity. She is widely recognized as a leader in the use of stem cells for vascular repair, as evidenced by her many invited lectures to preeminent national and international meetings and roles in organizing several major meetings in her field.
Lyne Racette, PhD, associate professor
Dr. Racette completed her PhD in experimental psychology at Carleton University in Ottawa, Canada, and her postdoctoral fellowship at the University of California San Diego. She then went on to become an assistant professor at Indiana University in 2010. Now, as an associate professor with the UAB Department of Ophthalmology, Dr. Racette leads a research team focused on improving the detection of change in glaucoma. Her work continues to be funded by the National Institutes of Health as well as private sources. She has developed a model to assess glaucoma progression that jointly uses structural and functional data. Dr. Racette is an advocate for diversity in science and has served as the chair of the Diversity Initiatives Committee of the Association for Research in Vision and Ophthalmology.